PCN72 COMPARATIVE COST ANALYSIS OF SUBCUTANEOUS TRASTUZUMAB ORIGINATOR (HERCEPTIN®) VS INTRAVENOUS TRASTUZUMAB BIOSIMILAR (KANJINTI) FROM A HOSPITAL PERSPECTIVE IN ITALY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.269
https://www.valueinhealthjournal.com/article/S1098-3015(19)32647-6/fulltext
Title :
PCN72 COMPARATIVE COST ANALYSIS OF SUBCUTANEOUS TRASTUZUMAB ORIGINATOR (HERCEPTIN®) VS INTRAVENOUS TRASTUZUMAB BIOSIMILAR (KANJINTI) FROM A HOSPITAL PERSPECTIVE IN ITALY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32647-6&doi=10.1016/j.jval.2019.09.269
First page :
Section Title :
Open access? :
No
Section Order :
10214